6 Things Investors should know about Hyphens Pharma (SGX: 1J5)
By SmallCapAsia  •  June 29, 2022
Hyphens Pharma is a speciality pharmaceutical and consumer healthcare group with a direct presence in five ASEAN countries, namely, Singapore, Vietnam, Malaysia, Indonesia, and the Philippines. We have written about its IPO back in 2018. You can read it over here. Its main 3 segments include: Specialty Pharma Principals segment Proprietary Brands segment Medical Hypermart and Digital segment. Specialty pharma principals segment engages in the business of selling and marketing specialty pharmaceutical products. Proprietary Brands segment develops markets and sells own proprietary range of dermatological products and health supplement products through Hyphens and Ocean Health Singapore. Medical Hypermart and Digital is engaged in the wholesale of pharmaceuticals and medical supplies in Singapore through Pan-Malayan. With that, lets check out 6 quick things to know about Hyphens Pharma. #1 Hyphens Pharma 5-Year Summary Hyphens Pharma has had a steady growth in its topline from $107. 4 mil in...
Read the full article
By SmallCapAsia
Our slogan is simple: Start Small, Win Big! What does it mean? Simply put, we want you to invest your small pockets of money and eventually have them balloon into hoards of cash in the long run – so that you can live your dream lifestyle and most importantly, retire comfortably without having to worry for another day.

Your email address will not be published.


Your Email Address will not be published

Read More Articles
More from thefinance